USL-311
- Generic Name
- USL-311
- Drug Type
- Small Molecule
- Chemical Formula
- C24H34N6O
- CAS Number
- 1373268-67-7
- Unique Ingredient Identifier
- 2BTG5MX2Q2
- Background
USL-311 is under investigation in clinical trial NCT02765165 (Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath